The Impact of Protein Intake on Protein Metabolism During Intensified Training

March 28, 2019 updated by: Daniel Moore, University of Toronto

The Impact of Protein Intake on Amino Acid and Protein Metabolism, and Performance During Intensified Training

Protein requirements in individuals who participate in endurance-based exercise training have been suggested to be greater than the current recommended dietary allowance (RDA).

Our recent study using the minimally invasive indicator amino acid oxidation (IAAO) technique have suggested that protein requirements in young men are at least 30% higher than the recommended protein intake.

The present study will investigate the impact of protein sufficiency on protein metabolism and performance during intensified training periods as a means to further our understanding of the nutritional requirements for the endurance athlete.

Study Overview

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5S 2C9
        • Goldring Centre for High Performance Sport

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Healthy, male, endurance-trained participants who have run regularly more than 45 km or 4.5 hours/week
  • Participants who are categorized at least "very good" based on a study by Shvartz & Reibold [40], in which peak rate of oxygen consumption(VO2 Peak) is used as an index. (i.e. the participants whose VO2peak is ≥57 ml/kg/min (18-24 y), ≥54 ml/kg/min (25-29 y), ≥52 ml/kg/min (30-34 y), ≥49 ml/kg/min (35-39 y), ≥47 ml/kg/min (40-44 y), ≥44 ml/kg/min (45-50 y) according to his age,
  • Participants who can cover 10 km in less than 60 min after the VO2peak test and 5 km Time trial on session 2.
  • Participants will be 18-50 years old.
  • Participants are willing to abide by the compliance rules of this study

Exclusion Criteria:

  • Inability to meet health and physical activity guidelines according to the The Physical Activity Readiness Questionnaire for everyone.
  • Female
  • Inability to adhere to any of the compliance rules judged by principal investigator or medical doctor
  • Regular tobacco use
  • Illicit drug use (e.g. growth hormone, testosterone, etc.)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Normal protein intake
participants will receive the controlled-diet containing 0.8 g protein /kg/day and the test drink containing 0.14 g protein/kg/d.
test drink which contains low amount of amino acids (0.14 g/kg/day)
the diet containing 0.8 g protein /kg/day
Experimental: Moderate protein intake
participants will receive the controlled-diet containing 1.20 g protein /kg/day and the test drink containing 0.40 g protein/kg/d.
the diet containing 0.8 g protein /kg/day
test drink which contains moderate amount of amino acids (0.40 g/kg/day)
Experimental: High protein intake
participants will receive the controlled-diet containing 1.83 g protein /kg/day and the test drink containing 1.03 g protein/kg/d.
the diet containing 0.8 g protein /kg/day
test drink which contains high amount of amino acids (1.03 g/kg/day)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in 24h whole body protein balance
Time Frame: Difference between day 1 and day 4 whole body protein balance
Protein balance (mg/kg/d; protein synthesis - protein breakdown) will be measured using [15N]Glycine method on day 1 and day 4 to determine the change over the intensified training period to compare between protein levels
Difference between day 1 and day 4 whole body protein balance

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline physical performance (5 km time trial) 5days after the beginning of training
Time Frame: 5days after the beginning of training
Before and after 4 days of intensified training period, Duration (seconds) for completing 5-km running on treadmill will be measured.
5days after the beginning of training
change from baseline Physical performance (muscle strength) 5days after the beginning of training
Time Frame: 5days after the beginning of training
Maximal strength will be assessed by a maximal isometric voluntary contraction (MVC), which will be tested for the knee-extensors using a custom-made knee-extension apparatus after 4 days intensified training.
5days after the beginning of training
change from baseline Physical Performance (muscle power) 5days after the beginning of training
Time Frame: 5days after the beginning of training
Peak lower body power will be measured by force platform after 4days-intensified training.
5days after the beginning of training

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Creatine Phosphate Kinase activity on day 5
Time Frame: 5days after the beginning of training
Muscle damage markers (blood Creatine Phosphate Kinase activity, IU/L) will be compared between the experimental arms 5days after the beginning of training
5days after the beginning of training
Myoglobin concentration on day 5
Time Frame: 5days after the beginning of training
Muscle damage markers (blood Mb Concentration, mg/mL) will be compared between the experimental arms 5days after the beginning of training
5days after the beginning of training
IL-6 concentration on day 5
Time Frame: 5days after the beginning of training
inflammatory markers (IL-6 concentration, pg/ml) will be compared between the experimental arms 5days after the beginning of training
5days after the beginning of training
CRP concentration on day 5
Time Frame: 5days after the beginning of training
inflammatory markers (CRP concentration, mg/L) will be compared between the experimental arms 5days after the beginning of training
5days after the beginning of training
amino acid concentration on day 5
Time Frame: 5days after the beginning of training
amino acid concentration (mmol/mL) will be compared between the experimental arms 5days after the beginning of training
5days after the beginning of training

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Daniel Moore, Ph.D., Faculty of Kinesiology and Physical Education, University of Toronto

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2016

Primary Completion (Actual)

September 1, 2017

Study Completion (Actual)

February 1, 2018

Study Registration Dates

First Submitted

May 25, 2016

First Submitted That Met QC Criteria

June 10, 2016

First Posted (Estimate)

June 15, 2016

Study Record Updates

Last Update Posted (Actual)

March 29, 2019

Last Update Submitted That Met QC Criteria

March 28, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • PFE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Normal

3
Subscribe